Dishing The Science with Dr. Sue
Dishing The Science with Dr. Sue
✓

Does everyone with type 2 diabetes need to be screened for MASH/MASLD (‘fatty liver’)? What the new Diabetes Canada Guidelines recommend

00:06:11
Podcasts
RSS
Link
Lydfilen for denne episode er muligvis beskadiget How to fix it?

OM DENNE EPISODE

Two out of three people with type 2 diabetes have 'fatty liver disease' (now called MASH/MASLD).  Should everyone with prediabetes or type 2 diabetes be screened? Find out what the brand new Diabetes Canada Guidelines say here!

Learn more: https://drsue.ca/2025/09/does-everyone-with-type-2-diabetes-need-to-be-screened-for-mash-masld-fatty-liver-what-the-new-diabetes-canada-guidelines-recommend/

Any medical discussion on this podcast is intended to be of a general nature only, and is intended for a Canadian audience. This podcast is not designed to give specific medical advice to patients, nor to their health care providers. If you have a medical problem you should consult your own physician for advice specific to your own situation. Postings on this podcast represent the personal opinions of Dr. Sue Pedersen. They are not representative of, nor endorsed by, Alberta Health Services. This podcast is intended for the Canadian general public as well as Canadian allied health professionals.

Medicin
Ernæring
Medicin
Sundhed & fitness
Engelsk
Canada
BrugAPItil at hente denne episode iJSON

I DENNE EPISODE

Redigér disse tags

SØG BLANDT TIDLIGERE EPISODER

Søg efter gamle afsnit af Dishing The Science with Dr. Sue.
Integrer denne søgefelt på dit websted

ANDRE EPISODE I DENNE PODCAST

GLP-1 in a pill for weight loss - pinning down where we're at

GLP-1 in a pill for weight loss - pinning down where we're at

While we now have several injectable GLP-1s based treatments for weight management around the world [liraglutide (Saxenda), semaglutide (Wegovy), tirzepatide (Zepbound/Mounjaro)], there are no GLP-1s currently available in a pill format for obesity treatment. But that is likely soon to change, back…
00:07:39
DEL
GEM
Wading through all the ways to diagnose obesity - can we find our way to a simple common ground?

Wading through all the ways to diagnose obesity - can we find our way to a simple common ground?

Obesity expert groups around the world have created guidance documents to reframe the diagnosis and assessment of obesity, to look beyond BMI, and embracing weight-related health issues, which differ in their approaches. Today I'm talking about how we can distill these down into one very simpl…
00:05:09
DEL
GEM
Do weight management medications improve Quality of life?

Do weight management medications improve Quality of life?

Improving quality of life is a central goal in successful weight management.  Do weight loss medications improve quality of life? Are there situations where quality of life could get worse, rather than better?  Learn more: https://drsue.ca/2025/09/do-weight-management-medications-improve-quality-of…
00:04:13
DEL
GEM
Can GLP-1 medications cause funky skin sensations (dysesthesia)?

Can GLP-1 medications cause funky skin sensations (dysesthesia)?

Can GLP-1 medications cause altered skin sensations? Find out what we know here. Learn more: https://drsue.ca/2025/10/can-glp-1-medications-cause-funky-skin-sensations-dysesthesia/ Any medical discussion on this podcast is intended to be of a general nature only, and is intended for a Canadian audi…
00:04:45
DEL
GEM
Ansvarsfraskrivelse: Podcasten og kunstværket, der er indlejret på denne side, er fra Dr. Sue Pedersen, som tilhører dens ejer og ikke er tilknyttet eller godkendt af Listen Notes, Inc.
PROMOTED
We’re selling some of our podcast-related domain names, including breaker.fm, Podcast.mov, and Listen.Host. Place your bid on eBay.
We’re selling some of our podcast-related domain names, including breaker.fm, Podcast.mov, and Listen.Host. Place your bid on eBay.
Bid on eBay

ANBEFALINGER
Brug API til at hente denne episode